Revefenacin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 30: | Line 30: | ||
==Brand Names== | ==Brand Names== | ||
*Yupelri |
Revision as of 21:17, 7 October 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Uma Maveli[2]
Overview
Adult Indications and Dosage
Pediatric Indications and Dosage
Contradictions
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
IV Compatibility
Pharmacology
Clinical Studies
How is it supplied
Patient Counseling Information
Precautions with Alcohol
Brand Names
- Yupelri